PTK2 and glioblastoma: Overall, the FAK+MEK inhibitor combination showed synergistic or potent additive effects across multiple GBM stem cell lines in 2D, and we were able to replicate these drug combination results via live cell imaging in a 3D spheroid invasion assay (Figure 6).